about
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B studyDNA sequencing of a cytogenetically normal acute myeloid leukaemia genomeHigh throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samplesEmerging technologies in paediatric leukaemiaMolecular prognostic factors in cytogenetically normal acute myeloid leukemiaThe prognostic and functional role of microRNAs in acute myeloid leukemiaTET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemiaRUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitationsClinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise reviewGenomic and epigenomic landscapes of adult de novo acute myeloid leukemia.Translating microarray data for diagnostic testing in childhood leukaemia.Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH dataThe complexity of interpreting genomic data in patients with acute myeloid leukemia.Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial.Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations.SNPExpress: integrated visualization of genome-wide genotypes, copy numbers and gene expression levels.Array CGH in human leukemia: from somatics to genetics.Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimenE-26 Transformation-specific Related Gene Expression and Outcomes in Cytogenetically Normal Acute Myeloid Leukemia: A Meta-analysis.Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.Genomic imbalances are confined to non-proliferating cells in paediatric patients with acute myeloid leukaemia and a normal or incomplete karyotype.Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8.Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm.An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemiaPrognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogenetics6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group studyComparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remissionMolecular signatures in acute myeloid leukemia.Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.Acute myelogenous leukemia at Baylor Charles A. Sammons Cancer Center, 2010 to 2012: retrospective analysis of molecular genetic evaluation.Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy.Up-regulation of anti-apoptotic genes confers resistance to the novel anti-leukaemic compound PEP005 in primary AML cellsImpact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.
P2860
Q24536351-E9672A27-03FE-4861-B0E5-50497D43457FQ24643738-6232C491-A96D-4C68-96E1-6D201261A1D9Q24644436-6EF6DCD5-F0AA-4A17-AEF8-6369FD35FD5FQ24652901-F6D47DF9-8E26-4530-BCC1-A984EE182C38Q26770327-A5FBD81C-4325-4229-A1F0-F92BA7DC45BEQ26998811-483AE480-32B0-4DBB-A043-1732332CC59EQ27693865-2AD310B7-9DD2-4733-B169-D9F053A8B8C8Q27851621-F2E7C1D1-9984-4823-9520-6DBF5ED9A997Q27851679-037F77EB-BE17-48C8-90DB-104C01C9EAB7Q27851713-1B51FFF9-0E95-4FF7-BA1C-B86A42182DD9Q27851839-7732C80F-60D2-47C2-B677-65CB32801AC9Q27852644-F7521CFA-FCBE-47AC-8E4E-4BB21033A5C8Q28289859-727A1FEB-9680-4A48-8539-C4A42E383120Q28301344-C050A3B3-83DA-4353-99B0-170425474F65Q29615735-A80FEBA7-A6F7-4801-AB51-A20175892CB6Q31062604-14898044-ACFF-404D-B9DD-A8D62A1D3E65Q31140388-C1373790-A76C-4AA4-8FD3-6C1C18D23B34Q31149503-ACB20B16-E00B-4D6F-8926-948105450439Q33264716-B84678B9-0443-43E7-A492-0969D4003497Q33309313-BF4ADC0B-F7A7-4724-9331-BB0CA76847A0Q33316565-63344C70-152D-405F-BE40-849D913404ECQ33397024-B4ED881A-BD9C-4374-B7BC-27BBF03C748BQ33401001-68C5839F-3372-4279-8696-40A25ED80003Q33645271-47C5358D-2FD6-41ED-9AD1-DA673C7BFA9AQ33776896-E3F67BDB-55F8-482C-842C-B19D9E48140BQ33822055-8574F027-0EF1-4F71-8808-216879222CC7Q33897586-0E496588-2FBA-4B1A-BB1A-73C5BCAFFF1BQ33939071-B7B7F9E9-955D-4813-8FFC-39802B5CA639Q34119417-6F348F14-8FCA-441B-B4B1-D8F15C3E3FE5Q34193514-7077342F-D539-4039-8BD9-4F891E95F463Q34197535-7ECD6655-8BAC-4BA0-8691-E42BD6878A06Q34205736-862CB38D-62AF-4004-96E3-0391D19ECDDEQ34318474-341B848C-57C8-4238-AC68-50E9703A78B3Q34401926-B4B31261-A789-4189-A8EC-0F8AC90476FCQ34403639-B4C27CC5-B1AC-4DC6-8905-70C0539B902DQ34477821-99A3E7C0-1A31-4CB7-8314-1A5C774CB07AQ34632079-0D4B1801-A136-491A-AEAB-4A3C87CE65B5Q34663691-03CF6890-09A8-4E4F-BBE2-3BE021B571CAQ34781362-A280EB6D-1DAD-45D2-B13A-CE0226AD015CQ34877613-1B89E1D9-0059-4D83-BF18-BC7096493305
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cytogenetics in acute leukemia.
@ast
Cytogenetics in acute leukemia.
@en
Cytogenetics in acute leukemia.
@nl
type
label
Cytogenetics in acute leukemia.
@ast
Cytogenetics in acute leukemia.
@en
Cytogenetics in acute leukemia.
@nl
prefLabel
Cytogenetics in acute leukemia.
@ast
Cytogenetics in acute leukemia.
@en
Cytogenetics in acute leukemia.
@nl
P50
P1433
P1476
Cytogenetics in acute leukemia.
@en
P304
P356
10.1016/S0268-960X(03)00040-7
P577
2004-06-01T00:00:00Z